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Abstract: Lung cancer continues to be a difficult disease frequently 
diagnosed in late stages with a high mortality and symptom bur-
den. In part because of frequent lung comorbidity, even lung can-
cer survivors often remain symptomatic and functionally limited. 
Though targeted therapy continues to increase treatment options 
for advanced-stage disease, symptom burden remains high with few 
therapeutic options. In the last several decades, exercise and physi-
cal activity have arisen as therapeutic options for obstructive lung 
disease and lung cancer. To date, exercise has been shown to reduce 
symptoms, increase exercise tolerance, improve quality of life, and 
potentially reduce length of stay and postoperative complications. 
Multiple small trials have been performed in perioperative non–
small-cell lung cancer patients, although fewer studies are available 
for patients with advanced-stage disease. Despite the increased inter-
est in this subject over the last few years, a validated exercise regimen 
has not been established for perioperative or advanced-stage disease. 
Clinicians underutilize exercise and pulmonary rehabilitation as a 
therapy, in part because of the lack of evidence-based consensus as to 
how and when to implement increasing physical activity. This review 
summarizes the existing evidence on exercise in lung cancer patients.
Key Words: Exercise, Physical activity, Non–small-cell lung cancer, 
Small-cell lung cancer, Quality of life.
(J Thorac Oncol. 2015;10: 861–871)
Lung cancer is the second most common cancer type, is the leading cause of cancer death, and is expected to comprise 
13% of new cancer diagnoses (224,210 new cases) with 159,260 
deaths in 2014.1 Though improved understanding of cancer biol-
ogy and targeted therapies is improving outcomes, 1-year and 
5-year survival rates remain low at 43% and 17%, respectively.1 
Furthermore, lung cancer patients have high symptom burden 
including dyspnea, cough, fatigue, anxiety, depression, insomnia, 
and pain.2,3 Even lung cancer survivors more than 5 years from 
diagnosis experience quality of life (QoL) impairment in 35% of 
cases4 and report lower physical and health scores compared with 
healthy patients.5 Interestingly, the patients who experience QoL 
improvement after therapy (15%) have no change in symptom 
burden, suggesting an adaptation to chronic symptoms.4
Lung cancer patients are in a uniquely difficult situation 
in that their disease, their comorbidities, and their treatment 
may all lead to worsened symptomatology.6 Chronic obstructive 
pulmonary disease (COPD) is present concomitantly in 73% of 
men and 53% of women with newly diagnosed primary lung 
cancer.7 The diverse causes of activity limitation are listed by the 
2013 American Thoracic Society/European Respiratory Society 
(ATS/ERS) statement on pulmonary rehabilitation (PR) and 
include ventilatory or gas exchange limitations, cardiac limi-
tation, lower limb or respiratory muscle dysfunction, anxiety, 
depression, and poor motivation.8 Chemotherapy-induced ane-
mia, radiation-induced pneumonitis, and lung resection-related 
impairment are frequently seen and likely contribute to dyspnea 
and fatigue.6,9,10 With significant cancer burden and rising cancer 
costs (estimated $86.6 billion in 2009),1 an inexpensive cancer 
therapy to relieve symptoms and improve QoL is appealing.
Inactivity and low-exercise tolerance are increasingly 
recognized in chronically ill patients. Multiple studies show 
lower activity and daily step counts in COPD, peripheral vas-
cular disease, and non–small-cell lung cancer (NSCLC).11–15 
In COPD, for example, physical inactivity is often seen during 
exacerbation and a predictor of poor outcome.16,17 The same 
pattern is seen in pulmonary hypertension, interstitial lung 
disease, and lung cancer.3,18
Adding to their burden, functional capacity significantly 
declines after lung cancer diagnosis.19,20 In a recent longitudinal 
trial, 36% of lung cancer patients (all stages) were noted to reduce 
or stop walking exercise over the course of 6 months.21 The term 
“dyspnea spiral” has been utilized to describe the development 
of dyspnea, activity avoidance to prevent further dyspnea, and 
resultant further loss of function. Some estimates suggest up to 
1 of 3 of loss in functional capacity in cancer patients is because 
of prolonged physical inactivity.19 Historically, providers and 
caring family members have contributed to physical inactivity 
by recommending rest to reduce symptom burden, leading to 
further deconditioning.22 Lung cancer patients with lower exer-
cise tolerance have worse surgical outcomes, chemotherapy 
response and tolerance, and survival.3
In the last 20 years, increasing physical activity has shown 
great promise for cancer and chronic lung disease therapy. 
Because of the significant overlap between lung cancer and 
chronic lung disease (namely COPD), lung cancer patients may 
benefit from physical activity more than other cancer patients. 
Indeed, exercise therapy represents a low-cost way to improve 
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symptoms and potentially outcomes in lung cancer. Given the 
potential benefit of exercise in this population coupled with the 
lack of clear recommendations for clinicians providing care, we 
will review the literature to date on exercise, physical activity, and 
lung cancer.
Before summarizing the literature, a distinction between 
“physical activity” and “exercise” should be made. Caspersen 
et al.23 defined and distinguished these terms previously. They 
described physical activity as “a bodily movement by skeletal 
muscles that results in energy expenditure.” Exercise is physi-
cal activity that is planned, structured, and repetitive with the 
goal to obtain or maintain physical fitness.23 This review’s 
goal is to summarize the effect of increased physical activity 
on lung cancer outcomes. As such, studies utilizing increased 
physical activity, exercise regimens, or PR are often compared 
side-by-side. Although the methods differ in application, lung 
cancer patients likely benefit through increased overall physi-
cal activity rather than the regimen itself. As the reader will 
see, compliance is an often cited challenge in patients with 
chronic lung disease, and the regimen that maximizes com-
pliance may be the most effective. Indeed, utilizing an exer-
cise regimen or rehabilitation may have more or less benefit 
than simply increasing physical activity. However, these two 
regimens have not yet been directly compared. As such, this 
review will consider physical activity, exercise regimens, and 
PR as methods to increase physical fitness that may improve 
cancer outcomes.
The existing literature lacks a review that includes 
the progression of exercise’s benefit in cancer and lung dis-
ease, evaluation of both medically and surgically treated 
lung cancer patients, and the growing interest of pedometer/
accelerometer studies in patients with exercise limitation. To 
address these issues cohesively, PubMed was searched for the 
terms “physical activity,” “exercise,” “lung cancer,” “pedom-
eter,” and “step counts.” Resulting articles were individu-
ally reviewed by B.C.B. for their applicability to the topic 
and included as referenced to create this narrative review. 
Additional articles outside the searched terms were included 
to appropriately summarize the existing literature or provide 
sufficient topical background.
REDUCED CANCER INCIDENCE, MORTALITY, 
AND SYMPTOM BURDEN
Growing evidence supports activity’s benefit in primary 
and secondary cancer prevention. Much of this work has been 
done in colon and breast cancer. In 2009–2010, several large 
trials showed that cardiorespiratory fitness was associated 
with reduced breast cancer mortality, reduced risk of colon 
(and overall) cancer development, and reduced mortality with 
gastrointestinal cancers.24–26 Reduced lung cancer incidence 
with higher activity was confirmed in a 2013 review.27 In fact, 
physical activity reduces risk of cancer development in mul-
tiple cancer types (colon, breast, prostate, pancreatic, endo-
metrial, ovarian, and lung).28
In many cancer types, increased physical activity is also 
associated with reduced cancer-associated mortality. Large 
trials in Taiwan (n = 416,175 patients followed for ~8 years) 
and by the National Institutes of Health (NIH) (n = 293,511) 
showed exercise’s association with reduced all-cause mor-
tality,29 and that self-reported moderately vigorous physi-
cal activity led to lower risk of all-cause and cancer-specific 
mortality (colon, liver, and lung), respectively.30
Multiple trials have also shown reduced symptom bur-
den with increased activity. Specifically, exercise can also be 
used as an adjunctive therapy for cancer-related symptom 
relief during and after cancer treatment.28 In a randomized, 
controlled trial (RCT), Segal et al.31 showed that breast cancer 
patients not receiving chemotherapy increased their subjective 
physical functioning with an exercise regimen. Interestingly, 
the patients who directed their own regimen appeared to have 
equal or better improvements. In 2005, Douglas19 reviewed 
breast and metastatic tumors, noting that exercise benefited 
functional capacity, strength, hospital stay, QoL, energy, and 
fatigue. In hospitalized patients receiving myeloablative che-
motherapy, one study found benefit symptom control, cogni-
tive function, and psychosocial function during therapy.32
A systematic Cochrane review in 2012 focused on 
exercise intervention and QoL in cancer patients receiving or 
planning active treatment. Fifty-six trials were included (4826 
patients) and concluded that exercise interventions may have 
beneficial effects on QoL, physical function, social function, 
and fatigue.33 The effects were more noticeable with the mod-
erate and vigorous intensity programs.
Is Physical Activity Appropriate?
Some clinicians have recommended limited activity in 
cancer patients ostensibly to avoid worsening symptoms. To be 
sure, lung cancer patients limit activity to avoid the “dyspnea 
spiral.” Similarly, supporting families often limit activity in 
the cancer patient to prevent acute symptoms. Before advocat-
ing more activity, the safety of increasing physical activity in 
lung cancer patients needs to be established. Research regard-
ing the feasibility and safety of exercise perioperatively (see 
Table 1),34,35 in advanced NSCLC (see Tables 2 and 3),36 and 
in advanced-stage lung cancer undergoing chemotherapy37 has 
been performed and is reviewed here.
Several novel studies utilizing a patient-centered approach 
were recently performed. By surveying NSCLC survivors 
(average 3.6 years from surgical treatment), Philip et al.38 found 
that most patients desire physical activity advice before cancer 
treatment, in a face-to-face fashion, from a physician at a can-
cer center. Another survey-based study in advanced lung cancer 
patients revealed that patients preferred activity recommenda-
tions from their oncologist, though none had received specific 
advice.39 These patients also perceived that a lack of recommen-
dation from their physician constituted an acceptance of their 
exercise regimen. An uncontrolled trial of lung cancer patients 
(all stages) in 2013 reported ~70% of patients who completed a 
training program remained physically active.40 These data high-
light that lung cancer patients (regardless of stage) desire exer-
cise guidance and can increase compliance with a dedicated 
regimen, yet such discussions are often not held.
BENEFITS IN LUNG CANCER
In 2005, the National Emphysema Treatment Trial (pro-
spective, multicenter trial with 1218 patients) revealed that 
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PR before and after lung volume reduction surgery improved 
exercise tolerance, dyspnea, and QoL.41 With the frequent 
coexistence of lung cancer and COPD, studies evaluating 
PR and increased activity in lung cancer have become more 
frequent. Despite multiple small trials evaluating physical 
activity in lung cancer patients, the evidence is difficult to 
generalize secondary to differences in the populations stud-
ied. That is, exercise is applied to patients in limited-stage, 
advanced-stage, perioperative, home-based, and inpatient set-
tings. As such, disease presentations need to be reviewed indi-
vidually to provide appropriate context.
Perioperative Exercise
Holden et al.42 recognized the potential importance of 
activity in lung cancer in 1992. The group noted that lower 
exercise tolerance (through cycle ergometer, 6-minute walk 
TABLE 1.  Surgical Studies (n = 22)
Author Patients Regimen N Result
Sekine et al.68 NSCLC with COPD undergoing  
lobectomy
Preoperative-PR (2 weeks) with 
postoperative CPT
22 FEV1 preservation, shorter LoS, fewer 
pulmonary complications
Spruit et al.50 NSCLC and SCLC pts after treatment  
(9 surgeries; 1 chemoradiation)
Posttreatment PR (8 weeks; inpatient) 10 Improved 6MWD and cycle ergometry
Cesario et al.51 Lung cancer, preoperative Preoperative-PR (4 weeks) 8 Improved operability
Jones et al.54 Suspected stages I–IIIA NSCLC Preoperative cycle ergometry for 5 sessions 20 Improved 6MWD and VO2
Bobbio et al.66 NSCLC (stage I or II), COPD,  
and VO2 <15
Preoperative-PR (4 weeks) 12 Improved VO2 to >15 ml/kg/min
Pehlivan et al.56 NSCLC (stages I–IIIB) Preoperative physical therapy 60 Improved LOS, SaO2, exercise capacity, 
V/Q distribution
Arbane et al.57 NSCLC referred for VATS Postoperative exercise regimen (12 weeks, 
inpatient and outpatient)
53 No change in QoL or 6MWD. Reduction 
in quadriceps strength loss
Benzo et al.69 Lung cancer and moderate/ 
severe COPD
Preoperative-PR (10 sessions) 19 4 weeks of preoperative-PR difficult to 
implement; shorter chest tube times and 
nonsignificant reduced LOS
Granger et al.34 Adults undergoing lung resection  
for suspected lung cancer
Postoperative, twice daily sessions as 
inpatient and twice weekly sessions as 
outpatient (8 weeks)
15 (LC 10) Exercise was safe and feasible. 57% of 
patients participated outpatient therapy
Divisi et al.52 NSCLC (stage I) and COPD Preoperative-PR (4 weeks) 27 Improved PaO2, VO2, and FEV1. Reduced 
inoperability
Stigt et al.60 NSCLC, resectable Postoperative-PR (twice/week for  
12 weeks)
49 No change in QoL. Exercise tolerance 
improved. More reported pain and 
limitations
Coats et al.87 NSCLC before resection Preoperative, home-based exercise regimen 
(exercise 3×/week for 4 weeks)
16 Improved exercise tolerance and muscle 
strength
Sterzi et al.59 NSCLC undergoing resection Postoperative PR, inpatient for 3weeks 110 Improved exercise tolerance (through 
6MWT)
Stefanelli et al.67 NSCLC (stages I and II) and COPD Preoperative-PR (3 weeks) 40 Improved VO2 and maintained after 
surgery
Hoffman et al.86 NSCLC undergoing thoracotomy 
(stages I–IIIA)
Light intensity walking and balance (Wii; 
Nintendo, Redmond, WA) for 6 weeks
7 Feasible. Improved cancer-related fatigue, 
walking, balance, and # steps/day)
Bradley et al.35 Presumed lung cancer undergoing 
curative surgery
Preoperative and postoperative 
rehabilitation program, multidisciplinary
58 Feasible. Improvement in 6MWD and 
FEV1 (Preoperative portion). 54% quit 
smoking
Morano et al.55 NSCLC undergoing resection and 
abnormal spirometry
Preoperative-PR (4 weeks) 24 Preoperative-PR reduced fibrinogen and 
improved functionality and QoL
Brocki et al.89 Lung cancer patients after chest 
surgery
Outpatient weekly sessions for 10weeks 78 No QoL or symptom benefit after 1 year 
(pain benefit at 4 months)
Arbane et al.58 NSCLC undergoing resection Postoperative inpatient exercise (for 4 
weeks) and recommended outpatient 
regimen
131 No change in physical activity, strength, 
or QoL. If airflow obstruction, QoL 
improvement
Chang et al.80 NSCLC undergoing lobectomy Postoperative walking (12 weeks) 66 Improved FEV1, FVC, and 6MWT
Hoffman et al.79 NSCLC undergoing thoracotomy and 
chemotherapy
Walking and balance exercises (Wii) for 
16 weeks
5 Trends toward symptom, functionality, and 
QoL improvement
Mujovic et al.70 NSCLC undergoing resection and 
COPD
Preoperative-PR (2–4 weeks) 83 Improved exercise tolerance, FEV1, FVC, 
and dyspnea
NSCLC, non–small-cell lung cancer; SCLC, small-cell lung cancer; COPD, chronic obstructive pulmonary disease; PR, pulmonary rehabilitation, CPT, chest physiotherapy; FEV1, 
forced expiratory volume in 1 second; LoS, length of stay; QoL, quality of life; 6MWD, 6-minute walk distance; FVC, forced vital capacity; pts, patients; V/Q, ventilation-perfusion.
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distance [6MWD], and stair climbing) was associated with 
poorer postoperative outcome.42 Conversely, higher maximum 
and peak oxygen consumption (VO
2
) are associated with 
improved postoperative survival and improved all-cause mor-
tality in early-stage NSCLC, respectively.43,44 The suggestion 
that more active patients had better outcomes has given rise to 
significant interest in evaluation of lung cancer patients before 
surgery.
The treatment for early-stage lung cancer (stages I 
and II) is surgery,45 and patients have increased surgical risk 
related to obstructive lung disease.42,46 Unfortunately, pulmo-
nary resection is associated with activity reduction at 1 month 
(larger resections being more debilitating)47 and reduced func-
tional health status and worse pain scores at 6 months.48 As 
such, many activity studies have focused on preoperative and 
postoperative exercise regimens to try and minimize activity 
and functional loss.
The study approaches have been diverse. In 1997, 
Weiner et al.49 showed that incentive spirometry and inspi-
ratory muscle training before and after surgery increased 
muscle strength and forced expiratory volume in 1 second in 
COPD patients undergoing resection. A pilot study in 2006 
showed that an 8-week inpatient PR program after surgery 
led to improvements in exercise capacity through 6MWD and 
cycle ergometry.50 The following year, Cesario et al.51 reported 
an observational study where inpatient PR and smoking ces-
sation were achieved in patients previously refused for sur-
gery. In eight patients, surgery was subsequently able to be 
performed because of improved exercise tolerance with no 
mortality. A similar oxygen uptake improvement was noted by 
Divisi et al.52 with an outpatient PR program. These data sug-
gest that perioperative exercise in lung cancer patients might 
improve both operability and operative risk, though the stud-
ies are small.
A 2013 Cochrane review with three RCTs and 178 
patients evaluated exercise therapy in NSCLC patients within 
12 months of undergoing lung resection. Perioperative exer-
cise increased exercise capacity, although no change in QoL 
or strength was identified.53 The review noted that more stud-
ies were needed as they identified potential benefit but rec-
ognized small sample size and concerns about bias in the 
existing studies.
Both preoperative and postoperative regimens have 
subsequently been examined separately, with mixed results. 
Small trials in 2007 and 2014 showed that preoperative exer-
cise training increased 6MWD, increased VO
2
, and improved 
QoL before surgery.54,55 A RCT with 60 NSCLC patients con-
firmed improved oxygenation, exercise capacity, and length 
TABLE 2.  Medical Studies (n = 11)
Author Patients Regimen N Result
Temel et al.88 NSCLC (stage IIIb or IV),  
ECOG 0–1
8 weeks of twice weekly inpatient 
exercise sessions during cancer 
therapy
25 Program completers (11) had improved 
symptoms, though <50% could 
complete the program
Andersen et al.91 Lung cancer, any stage (able to 
walk >50 m)
7 weeks of twice weekly, outpatient 
sessions
45 <50% completed regimen. Improved 
incremental and endurance shuttle walk 
tests
Quist et al.37 NSCLC (stages III and IV) or 
SCLC (extensive stage)
Inpatient and home-based training 
sessions
29 Exercise interventions feasible, though 
low home adherence. Improved VO2, 
6MWD, and emotional well being
Cheville et al.74 Stage IV cancer (lung and colon) Home-based, incremental walking and 
strength training; 8 weeks.
66 (34 with LC) Improved mobility, fatigue, and sleep 
quality with low dropout rate
Andersen et al.40 Lung cancer (all stages) Outpatient, twice weekly exercise 
sessions and unsupervised sessions 
alternating (9 weeks total)
51 51% completed training. Of completers, 
69% continued daily physical activity. 
No change in VO2
Lin et al.21 Lung cancer (all stages) Walking exercise for 6 months 107 Walking stopped in 36% of patients. 
Improved QoL
Henke et al.73 Advanced NSCLC and SCLC Inpatient exercise sessions 5 days/
week during chemotherapy
46 29 completed. Improved physical 
function, hemoptysis, pain, and 
cognitive functioning scores; 6MWT 
strength, and dyspnea
Jensen et al.93 Metastatic cancer (23% lung) Therapist evaluation of appropriate 
exercise or therapy
528 (125 LC) Exercise/therapy feasible in >90% of 
patients
Kuehr et al.92 NSCLC (stages I–IIV) receiving 
chemotherapy or combined 
chemoradiation
Inpatient (5×/week) and outpatient 
(3×/week) sessions for 8 weeks
40 Exercise in feasible during cancer therapy 
and improved exercise tolerance, 
endurance, and strength
Granger et al.15 NSCLC (stages I–IIIB) before 
treatment
Step-counting for 6 months 50 GPS is feasible. NSCLC patients walk 
less than healthy patients
Granger et al.85 NSCLC (stages I–IIIB) during 
treatment
Step-counting for 6 months 50 NSCLC patients have less activity, are 
weaker, are more depressed, and less 
self-reported activity at 6 months
ECOG, Eastern Cooperative Oncology Group; NSCLC, non–small-cell lung cancer; COPD, chronic obstructive pulmonary disease; SCLC, small-cell lung cancer; 6MWD, 
6-minute walk distance; QoL, quality of life; LC, lung cancer; GPS, global positioning system; MD, medical doctor.
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of stay (LoS) with a preoperative exercise regimen.56 By con-
trast, a RCT on patients undergoing exercise intervention after 
thoracotomy showed no change in QoL or exercise tolerance 
(though perhaps a reduction in strength loss).57 More recent 
trials in NSCLC patients utilizing postoperative exercise regi-
mens have been mixed, finding potential change in walking 
distance but no change in strength or QoL.58,59 Stigt et al.60 
even noted increased pain and limitations with an early post-
operative PR regimen. These data suggest potential benefit in 
preoperative activity regimens but unclear benefit (and poten-
tially higher morbidity) in postoperative regimens.
In addition, at least four reviews of perioperative 
exercise in lung cancer have been performed recently.61–64 
All reviews found that exercise interventions were safe. In 
Granger et al.’s61 review, preoperative and postoperative activi-
ties were noted to increase exercise capacity and inconsistently 
effect QoL or symptom burden. Focusing on presurgical exer-
cise interventions (n = 966 patients) with cancer (especially 
lung cancer), Singh et al.62 found that exercise may improve 
physical function, improve QoL, and reduce LoS. Both 2014 
reviews found benefit in exercise treatment perioperatively 
for NSCLC patients undergoing resection (exercise capacity, 
muscle strength, fatigue, postoperative complications, and 
LoS).63 However, Rodriguez-Larrad et al.64 only noted benefit 
in the preoperative regimen. In summary, the evidence appears 
to show that exercise is safe perioperatively, functional status 
is improved with variable effects, and preoperative interven-
tions may be more beneficial (Tables 1 and 3).
PULMONARY REHABILITATION
After the National Emphysema Treatment Trial showed 
clinical benefit in COPD and subsequent trials showed reduced 
hospitalizations,65 many tried applying PR to lung cancer 
patients. The 2013 ATS/ERS’s statement on PR redefined 
the program’s goals. Whereas the 2006 definition focused on 
a multidisciplinary approach to improve symptom burden 
and functionality in chronic respiratory disease patients, the 
2013 definition further prioritizes “patient-tailored therapies” 
including exercise training, education, and behavior change to 
promote long-term adherence.8
TABLE 3.  Reviews (n = 9)
Author Patients Regimen, Review Type N Result
Thompson et al.2 Lung cancer Noninvasive interventions,  
systematic review
9 studies, 833 patients Nursing program reduced 
breathlessness, nursing follow-up 
provided equal satisfaction and 
symptom control (vs. MD follow-
up), and counseling improved QoL, 
exercise improved power perception
Shannon71 Lung cancer PR, systematic review N/A PR may improve performance status , 
VO2, QoL, and exercise tolerance in 
lung cancer
Granger et al.61 NSCLC Exercise intervention, systematic 
review
16 studies, 675 patients Exercise interventions are safe. 
Preoperative and posttherapy 
interventions improved exercise 
capacity and symptoms. QoL 
changes were inconsistent
Payne et al.36 NSCLC (stages IIIB  
and IV)
N/A, systematic review 5 studies (203 patients) Exercise is not harmful and may be 
beneficial (weight loss, strength, 
functional performance) though 
inconsistent
Singh et al.62 Cancer patients 
(predominantly lung 
cancer)
Physical exercise before surgery, 
systematic review
18 studies (966 patients) Preoperative exercise may increase 
exercise capacity, improve QoL, and 
reduce LOS
Cavalheri et al.53 NSCLC undergoing 
resection
Exercise training within 12 months 
of lung resection (Postoperative), 
Cochrane Review
3 RCTs (178 patients) Perioperative exercise may increase 
exercise capacity (through 6MWD). 
No change in QoL of strength
Rochester et al.3 Lung cancer patients PR (4–7 weeks), systematic review N/A PR increases exercise endurance, 
VO2, strength and may reduce LOS, 
chest tube time, and postoperative 
complications. In patients with 
chemotherapy, increases strength, 
endurance, and QoL
Crandall et al.63 NSCLC patients treated 
surgically (stages I–IV)
Exercise regimen preoperative, 
postoperative, or both, systematic 
review
28 studies Improved exercise capacity and 
strength; reduced fatigue, LOS, and 
postoperative complications
Rodriguez-Larrad 
et al.64
Lung cancer patients 
undergoing resection
Preoperative or postoperative PR, 
systematic review
8 studies (599 patients) Preoperative-PR improves functional 
capacity and postoperative 
morbidity. Not seen with 
Postoperative PR
PR, pulmonary rehabilitation; LoS, length of stay; QoL, quality of life; 6MWD, 6-minute walk distance.
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Two groups have shown increased VO
2MAX
 with preop-
erative-PR after a 4-week regimen in patients with lung can-
cer and COPD.52,66 A subsequent RCT showed that the oxygen 
consumption improvement was maintained postoperatively.67 
In addition to potentially offering surgery to patients previ-
ously considered “inoperable,” PR may improve postopera-
tive outcomes. In 2005, a small cohort of patients undergoing 
lobectomy received preoperative PR and postoperative chest 
physiotherapy. This regimen was associated with shorter stay, 
improved postoperative lung volumes, and reduced pulmonary 
complications.68 Benzo et al.69 showed preoperative PR in lung 
cancer patients with COPD resulted in shorter chest tube times 
and a nonsignificant reduction in LoS. A more recent prospec-
tive, single group trial by Mujovic et al.70 showed improvements 
in forced expiratory volume in 1 second, vital capacity, 6MWD, 
and dyspnea after preoperative PR. Gains were the most signifi-
cant in patients with the worst preoperative functional capac-
ity. That is, the most benefit might be gained in the patients 
least likely to otherwise participate in exercise. PR has been 
shown to improve performance status, chemotherapy-induced 
fatigue, and exercise tolerance71 with a 2014 review confirm-
ing improved exercise endurance, oxygen uptake, strength, 
endurance, and QoL.3 Multidisciplinary implementation has 
also noted up to 54% smoking cessation.35 To summarize, PR 
improves lung volumes, oxygen uptake, and exercise tolerance 
in patients with lung cancer and may improve “operability” 
while reducing postoperative complications (Tables 1 and 3).
Exercise in Advanced Disease
With encouraging results perioperatively, some groups 
have postulated benefit in advanced-stage lung cancer. Similar 
to COPD, functional capacity in advanced NSCLC is an inde-
pendent predictor of survival with ~13% reduced risk of death 
per 50 m increase in 6MWD.18 As one might expect, patients 
with advanced-stage disease have lower lung function, 
strength, walking distance, and QoL compared with patients 
with early-stage disease (stages I and II).72
Similar to perioperative studies, regimens have been 
diverse. Quist et al.37 developed a regimen of group training 
(with a physiotherapist) and home training for patients with 
advanced NSCLC and extensive stage small-cell lung can-
cer . Although home adherence was low (<10%), benefits in 
oxygen uptake, exercise tolerance, and emotional well being 
were recognized from the group sessions.37 Henke et al.73 per-
formed a RCT in advanced-stage lung cancer patients receiv-
ing inpatient chemotherapy; implementing daily endurance 
training and every-other-day strength training, the group noted 
improvements in physical function scores, self-reported symp-
toms (pain, neuropathy, cognitive functioning, and dyspnea), 
and exercise tolerance. A RCT in stage IV cancer (lung and 
colorectal) patients in 2013 showed that home-based exercise 
(walking and strength training) improved mobility, fatigue, 
and sleep quality.74 These data suggest that increased physi-
cal activity may improve exercise tolerance and symptom bur-
den in patients with advanced-stage lung cancer, although the 
location, duration, and intensity to be recommended are not 
clear. Though incompletely answered, these topics have been 
approached (Tables 2 and 3).
How Much Exercise?
Despite clear benefit to increased physical activity in 
cancer, a frequent question is “how much is enough?” The 
ATS/ERS 2013 PR statement recognizes this limitation: “In 
addition, it is not known how much improvement in physical 
activity is clinically relevant or meaningful (E32).”8 For com-
parison, the American Heart Association has recommended 
150 minutes per week of moderate intensity exercise for 
healthy patients.75 By contrast, a small trial showed the aver-
age time to breathlessness in patients with stages III and IV 
thoracic cancer (NSCLC, small-cell lung cancer, and meso-
thelioma) was 4 minutes.76
The popularity of step counting with pedometers or 
accelerometers has been rising, providing direct comparison 
between the activity of healthy and chronically ill patients. 
Ten thousand steps per day is an often-cited goal in healthy 
patients,77 although likely difficult to achieve in chronically 
ill patients. Estimates of normal step count in a healthy, active 
person have been 8000 to 10,000 steps per day.77,78 Given 
that monitored step counts in patients with chronic illness 
(e.g., peripheral vascular disease and COPD) are much lower 
(3400–5680),11,12,14 10,000 steps per day seems difficult to reach 
in lung cancer. However, a recent study showed improved QoL 
associated with patients who walk for exercise,21 suggesting 
less intense activity goals also have benefit. Furthermore, light 
intensity regimens in NSCLC after thoracotomy and stage IV 
cancer (lung and colon) showed potential to improve mobility, 
fatigue, functional status, QoL, and sleep quality using a step 
count74 or walking and balance regimen.79
Step counting has also been advocated for chronically 
ill patients as a way to increase physical activity whereas not 
overburdening the patient. Regimens as simple as postoperative 
walking have shown improved lung volumes and physical func-
tion.80 The promise of walking therapy is emphasized by the util-
ity of the 6MWD as an outcome predictor in congestive heart 
failure,6 COPD,81 preoperative NSCLC,42 and NSCLC patients 
undergoing chemotherapy.82 In several studies, the 6MWD was a 
superior predictor to cardiopulmonary exercise testing.42,81
Again, studied regimens vary significantly. A 2006 
review of physical activity in chronic disease reported benefit 
after moderate activity for 30 to 60 minutes per day or walking 
>1 hour per week.83 One large trial (nonmetastatic breast can-
cer) suggested the greatest benefit occurred after walking 3 to 5 
hours per week at an average pace.84 Two recent observational, 
multicenter, prospective studies were published, confirming 
feasibility of tracking physical activity in NSCLC patients and 
providing useful data for future studies. A pretreatment study 
with 50 NSCLC patients (stages I–IIIB) noted less activity 
(6200 vs. 8563 steps/d in healthy controls), higher depression, 
and lower motivation in cancer patients at diagnosis.15 In a 
similar study the same year (n = 50 patients with stages I–IIIB 
NSCLC), cancer patients were found to be weaker, have poorer 
nutrition, and self-reported activity that declined over 6 months 
after diagnosis compared with healthy controls.85
In summary, the research to date recognizes that chroni-
cally ill cancer patients have different exercise limitations than 
their healthy counterparts. Low intensity regimens such as 
daily walking or step-counting may provide a safe mechanism 
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to increase physical activity while identifying an individual 
patient’s activity limits.
What Location?
One should also give thought to the ideal location of 
exercise. On one hand, an inpatient or physical therapist-
guided session will optimize technique and safety. On the 
other hand, outpatient, self-directed regimens would certainly 
be cheaper and more convenient for the patient. Recent tri-
als have shown feasibility, increased exercise tolerance, and 
symptom relief.86,87 Many existing trials have utilized inpa-
tient regimens.34,37,50,57,58,73,88 However, there is some evidence 
that outpatient, self-directed regimens work as well or better. 
Brocki et al.89 studied 78 patients in 2014 with a RCT, show-
ing no QoL or self-reported functionality advantage to super-
vised exercise 12 months postoperatively. In fact, the trend 
was in favor of unsupervised exercise, though no significance 
was recognized. Though feasible, Jacobsen et al.90 found no 
benefit in QoL or LoS utilizing a self-directed exercise regi-
men before stem cell transplant. These conflicting results may 
suggest that self-directed regimens have potential benefit, 
though patient selection, exercise regimen, and how to imple-
ment the program are not yet clear.
Barriers
Several barriers exist in how best to study and imple-
ment physical activity programs in lung cancer patients. 
Comorbid disease (especially COPD) and high symptom 
burden make completion of an aggressive exercise regimen 
challenging. In an NIH study in 2009, less than 50% of par-
ticipants with lung cancer were able to complete an exercise 
study, despite improvements in dyspnea after completion.88 
Similarly, Andersen et al.91 noted a more than 50% dropout 
rate, with patients completing the intervention found to have 
improved exercise tolerance, though no change in QoL or 
pulmonary function. In 40 NSCLC patients (stages II–IV), 
Kuehr et al.92 showed 55% adherence of all patients (higher in 
patients immediately after the intervention) utilizing a com-
bined inpatient and outpatient exercise intervention. Patients 
completing the exercise intervention had improvements in 
6MWD and muscle strength. These studies highlight the evi-
dence to date; i.e., exercise has benefit in lung cancer patients, 
though it is difficult to implement.
With the potential benefit of increasing activity coupled 
with concomitant activity-limiting lung disease, low intensity 
interventions are being applied. Even noninvasive regimens 
(i.e., breathing techniques or counseling) have shown some 
benefit in symptom burden.2 Despite limited exercise toler-
ance, a large retrospective study of cancer patients receiving 
inpatient palliative care (n = 528, 24% lung cancer) showed 
that physical exercise or physical therapy were feasible in 
more than 90% of terminally ill cancer patients to achieve 
symptom relief, and physical exercise could be performed 
in 54%.93 Pedometer studies present an attractive alternative. 
Recent studies in NSCLC patients report step count data col-
lection 36–56% of the time, worsening with time from enroll-
ment.15,85 Feasibility studies of pedometer/accelerometer 
compliance have been performed in healthy,94 COPD,11,95,96 
and NSCLC15,85 patients. However, with frequent pulmonary 
comorbidity, cancer therapy, and symptom burden, maintain-
ing step count compliance is difficult.
LUNG CANCER SURVIVORS
Another interesting group is lung cancer survivors 
(defined as patients surviving 5 years after diagnosis). Despite 
definitive treatment, lung cancer survivors have persistent 
symptom burden, especially fatigue.97 Fatigue is more likely 
in patients with a history of pulmonary disease, depression, 
and anxiety97 and less likely in those meeting physical activity 
guidelines.97 With reduced symptoms in more active patients, 
the same benefits suggested in lung cancer patients (especially 
improved symptoms and QoL) might apply.
Similar to active lung cancer patients, recommendations 
for activity in lung cancer survivors are unclear. In a round-
table consensus statement for cancer survivors, the American 
College of Sports Medicine recommended avoiding inactivity, 
staying as active as conditions allow, and setting goals similar 
to healthy counterparts.98
How Does Activity Help?
The mechanisms of exercise as a therapy for cancer 
are incompletely understood. Suspected mechanisms include 
alteration in hormone metabolism, systemic inflamma-
tion, immune response, oxidative stress, cell cycle changes, 
increased p53, or increased apoptosis mediators with increased 
activity.55,99–102 Several bench studies suggest an alteration in 
the body’s immune response with exercise. In 1994, a mouse 
model with breast adenocarcinoma showed that moderate 
exercise can increase the phagocytic activity of intratumoral 
white blood cells, though no change in tumor size.103 A 2013 
study showed that Tai Chi in lung cancer patients (after resec-
tion) altered the ratio of interferon-producing CD
3
 to IL-4-
producing CD
3
.104 Karvinen et al.105 showed that exercise 
training may attenuate leukopenia associated with chemother-
apy in NSCLC therapy.
Because Virchow’s triad (hypercoagulability, venous 
stasis, and endothelial injury) is likely present in many can-
cer patients, the association between lung cancer and venous 
thromboembolic (VTE) disease may also play a role in activ-
ity. Lung cancer patients have higher risk of VTE disease 
(including deep vein thrombosis and pulmonary embolism) 
compared with the general population,106,107 worsened in those 
with advanced disease and undergoing chemotherapy.108 VTE 
disease in lung cancer patients is associated with higher health-
care utilization,109 though the effect on survival is unclear.110,111 
Combining higher morbidity without clearly worsened mor-
tality suggests that VTE disease could impair QoL and activity 
tolerance in lung cancer patients. Activity, then, may improve 
venous stasis and reduce VTE disease burden in patients with 
lung cancer. This topic deserves further study.
Several animal studies have evaluated the effect of 
exercise on lung tumors. Higgins et al.100 showed that daily 
exercise in mice with lung cancer slowed the growth of lung 
tumors. Paceli et al.112 showed anaerobic activity reduced 
the incidence of lung tumors in mice exposed to Urethane. 
Subsequent investigators suggested that aerobic activity did 
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not show benefit because of reactive oxygen species burden 
in untrained mice, suggesting that exercise before the lung 
stressor might be more beneficial.113
FUTURE DIRECTIONS
There are still large gaps in the published literature to 
be addressed. No definitive, large, prospective trials have been 
performed to evaluate the benefit of exercise in lung cancer 
patients. Second, the ideal mode, intensity, location, and dura-
tion of exercise have yet to be established. The lack of con-
sensus makes clinical recommendations challenging. Third, 
clinicians’ goal should be to personalize an activity or exercise 
regimen for the individual patient. To optimize compliance, 
unachievable goals must be identified. However, there may 
also be harm associated with excessive anaerobic activity. 
Filaire et al.102 note that intense exercise increases oxidative 
stress whereas moderate physical activity reduces oxidative 
stress, suggesting an ideal exercise intensity for maximal 
benefit. Although we might suspect more aggressive exercise 
regimens for younger, ostensibly more “functional” patients, a 
2013 prospective trial in advanced lung cancer noted that the 
younger group of patients (<50 years) had worse pulmonary 
function and exercise correlates (perhaps because of more 
advanced disease at diagnosis).114 Although poorer function in 
younger patients is probably not generalizable across different 
cancer groups, the finding does suggest that a single exercise 
protocol will not likely fit all patient groups.
CONCLUSION
In closing, applying exercise regimens or increasing 
physical activity in lung cancer patients has yet to show a 
mortality benefit. Though mortality is often the “standard pro-
cedure” in therapy implementation, QoL should not be over-
looked as a treatment goal in itself, especially in patients with 
frequently incurable disease. Decreased quality at end of life 
can lead to premature death, and many cancer patients view 
QoL as important as the duration of their survival.115 A land-
mark study in 2010 even showed that palliative care in patients 
with metastatic NSCLC could lead to increased survival.116
The evidence to-date suggests benefit of exercise in all 
stages of lung cancer and lung cancer survivors. The ideal 
mechanism of implementation, however, is not yet known. 
Exercise barriers are significant, yet survey studies showing 
patient desire for pretreatment counseling coupled with insuf-
ficient provider recommendations on the topic are concern-
ing. Home-based, low-intensity exercise and recent success 
with pedometer studies in COPD and lung cancer popula-
tions show promise in monitoring and implementing activity 
prescriptions.
With multiple small studies and varied approaches, 
application to clinical practice remains difficult. This review 
shows uniform recognition that exercise and physical activ-
ity are safe in lung cancer, patients are requesting increased 
activity counseling, and multiple studies and reviews show 
potential clinical benefit in QoL, exercise tolerance, and post-
operative complications. Furthermore, we know that inac-
tivity in cancer patients is associated with worse outcomes.3 
Therefore, clinicians should (at minimum) consider PR early, 
counsel against inactivity, and encourage physical activity in 
lung cancer patients of all stages and lung cancer survivors.
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